LOXO
Loxo Oncology, Inc
LOXO
LOXO
Delisted
LOXO was delisted on the 14th of February, 2019.
158 hedge funds and large institutions have $3.61B invested in Loxo Oncology, Inc in 2018 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 48 increasing their positions, 55 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
+17
Holders Change %
+12.06%
% of All Funds
3.63%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
36
Increased
48
Reduced
55
Closed
15
Calls
$16.8M
Puts
$34.9M
Net Calls
-$18M
Net Calls Change
-$18.2M
Top Buyers
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$46.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$43.1M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$31.1M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$25.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.3M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$10.7B |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$91.5M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$28.6M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$19.5M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$19.5M |
